title: [Effect of combined psychocorrection on dynamics of pain syndrome and psychological status of patients with spinal osteochondrosis].
abstract: OBJECTIVE
  To study effectiveness of a new psychocorrection method (combined use of neuroleptic trifluoperasine and psychorelaxation therapy using biological feedback) in rehabilitation of patients with long-term pain syndrome provoked by spinal osteochondrosis (SOC) to determine predictors of response to this method of psychocorrection.
  
  
  METHODS
  132 patients with SOC and associated pain syndrome were examined using pain assessing methods and psychological tests.
  
  
  RESULTS
  Psychocorrection including neuroleptic significantly raises the efficacy of SOC treatment and relieves pain, hypochondric fixations and depressive disorders. The reduction of pain syndrome intensity in the course of psychocorrection correlates with attenuation of hypochondric disorders and inclination to fixation. As to predictors of the treatment effect, the strongest relief of pain in psychocorrection was achieved in patients with hypochondric and anxiodepressive disorders.
  
  
  CONCLUSIONS
  Combined psychocorrection comprising minimal doses of neuroleptic trifluoperasine and psychorelaxation is effective in the treatment of SOC patients with long-term pain syndrome.
authors.forename: V P
authors.initials: VP
authors.lastname: Zaĭtsev
authors.forename: O G
authors.initials: OG
authors.lastname: Tiurina
authors.forename: T A
authors.initials: TA
authors.lastname: Aĭvazian
authors.forename: F E
authors.initials: FE
authors.lastname: Gorbunov
authors.forename: S G
authors.initials: SG
authors.lastname: Maslovskaia
mesh_terms: D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001416:Back Pain / Q000209:etiology / Q000523:psychology / Q000628:therapy*; D030141:Feedback, Psychological; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010007:Osteochondritis / Q000150:complications / Q000523:psychology* / Q000534:rehabilitation; D026741:Physical Therapy Modalities; D011615:Psychotherapy, Group; D013122:Spinal Diseases / Q000150:complications / Q000523:psychology* / Q000534:rehabilitation; D016896:Treatment Outcome; D014268:Trifluoperazine / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D014268:Trifluoperazine